Patent ID: 8633184

Claim:
A method of treating a disease or condition in a mammal, which disease or condition is affected by the modulation of PPAR delta receptors, wherein the disease or condition affected by the modulation of PPAR delta receptor is selected from the group consisting of diabetes, Metabolic X Syndrome, hyper-LDL-cholesterolemia, dyslipidemia and obesity; which method comprises administering to a mammal in need of such treatment a therapeutically effective amount of a compound or salt of Formula (I) wherein: X is a covalent bond, O, or S; R 1 and R 2 are independently selected from the group consisting of H, C 1-8 alkyl, and substituted C 1-8 alkyl, or R 1 , R 2 and the carbon atom to which they are attached together may form C 3-7 cycloalkyl; R 3 is H; R 4 and R 5 are independently selected from the group consisting of H, halo, C 1-8 alkyl, C 3-7 cycloalkyl, C 3-7 cycloalkyl-C 1-4 alkyl, C 3-7 cycloalkyloxy-C 1-4 alkyl, C 1-6 alkoxy-C 1-4 alkyl, C 6-10 aryl, heteroaryl, halo substituted C 1-4 alkyl, amino substituted C 1-4 alkyl, C 6-10 aryl substituted C 1-4 alkyl, cyano substituted C 1-4 alkyl, and hydroxy substituted C 1-4 alkyl; R 6 and R 7 are independently selected from the group consisting of H, halo, C 1-3 alkyl, halo substituted C 1-3 alkyl, C 1-3 alkoxy, and halo substituted C 1-3 alkoxy; n is 1; and Q is selected from the group consisting of